C. diff Guidelines and Prevention Resources

  • Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, McDonald LC. Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes. N Engl J Med 2020; 382:1320-1330. https://doi.org/10.1056/NEJMoa1910215
  • CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. http://dx.doi.org/10.15620/cdc:82532
  • Making Healthcare Safer: Stopping C. difficile Infections. CDC Vital Signs. March 2012. https://www.cdc.gov/vitalsigns/hai/stoppingcdifficile/index.html
  • Guh AY, Kutty PK. Clostridioides difficile Infection. Ann Intern Med. 2018; 169(7):ITC49-ITC64. https://doi.org/10.7326/AITC201810020
  • Guh AY, Adkins SH, Li Q, Bulens SN, Farley MM, Smith Z, Holzbauer SM, Whitten T, Phipps EC, Hancock EB, Dumyati G, Concannon C, Kainer MA, Rue B, Lyons C, et al. Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study. Open Forum Infect Dis. 2017; 4(4):ofx171. https://doi.org/10.1093/ofid/ofx171.